Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Summary

This phase I/II trial is studying the side effects and best dose of oxaliplatin in treating patients with newly diagnosed glioblastoma multiforme. Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing

Timeline

Start

2000-12

Primary completion

2007-01

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications